Exon duplication and divergence in the human preproglucagon gene
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, GIP-driven weight loss is synergistically enhanced by adjunct GLP-1R agonism47-49”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [49]
In the citing paper
“and while GIP-mediated weight loss is fully preserved in Glp1r-deficient mice45,49”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [49]
In the citing paper
“GIP-driven weight loss is also synergistically enhanced by adjunct GLP-1R agonism47-49,117.”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [49]
In the citing paper
“GIPR agonist treatment is equally effective in promoting weight loss in obese mice”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [49]
Citations
Cites
Detection of specific sequences among DNA fragments separated by gel electrophoresis
Southern, E. M. (1975) · Journal of Molecular Biology · doi:10.1016/s0022-2836(75)80083-0 · Cited by 32,249
[57] Sequencing end-labeled DNA with base-specific chemical cleavages
Maxam, A. M., & Gilbert, W. (1980) · Methods in Enzymology · doi:10.1016/s0076-6879(80)65059-9 · Cited by 14,315
Organization and Expression of Eucaryotic Split Genes Coding for Proteins
Breathnach, R., & Chambon, P. (1981) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.50.070181.002025 · Cited by 4,548
Atlas of protein sequence and structure
Chang, M.-Y., Dayhoff, M. O., Eck, R. V., & Sochard, M. R. (1965) · NASA Technical Reports Server (NASA) · Cited by 4,383
A catalogue of splice junction sequences
Mount, S. M. (1982) · Nucleic Acids Research · doi:10.1093/nar/10.2.459 · Cited by 3,797
Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing
Sanger, F., Coulson, A. R., Barrell, B. G., Smith, A. J. H., & Roe, B. A. (1980) · Journal of Molecular Biology · doi:10.1016/0022-2836(80)90196-5 · Cited by 3,407
Wahl, G. M., Stern, M., & Stark, G. R. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.8.3683 · Cited by 3,247
Gilbert, W. (1978) · Nature · doi:10.1038/271501a0 · Cited by 2,300
Atlas of Protein Sequence and Structure, 1966.
Hersh, R. T., Eck, R. V., & Dayhoff, M. O. (1967) · Systematic Zoology · doi:10.2307/2412074 · Cited by 1,779
The structure and evolution of the human β-globin gene family
Efstratiadis, A. (1980) · Cell · doi:10.1016/0092-8674(80)90429-8 · Cited by 1,375
Research works printed but not linked: 2
- Unger, R. H.& Orci, L. (eds) Glucagon, Physiology, Pathophysiology and Morphology of the Pancreatic A-cell (Elsevier, New York, 1981).
- O'Farrell, P. Focus 3 (3), 1–3 (1981).
Cited by
Items 501–595 of 595
The role of GLP-1 and GIP receptor agonists in the treatment of diabetes and obesity
Roskoski, R. J. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108365 · Cited by 1
For Weight Loss: Why Do GLP-1 Agonists Work, and How Can We Make Them Work Better?
Giang, C., Meng, J., Mohammad, M. A., Liu, Z., Wu, X., & Zhu, Y. (2026) · Biology · doi:10.3390/biology15161395 · Cited by 1
The Role of Central Nervous System Glucagon-Like Peptide-1 in the Regulation of Energy Balance
Barrera, J. G. (2009) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
Glucagonlike Peptides 1 and 2, Enteroglucagon, Glicentin, and Oxyntomodulin
Holst, J. J. (2006) · Elsevier eBooks · doi:10.1016/b978-012369442-3/50148-3 · Cited by 1
Molecular Biology of Gluco-Incretin Function
Klinger, S., & Thorens, B. (2008) · Springer eBooks · doi:10.1007/978-4-431-75452-7_16 · Cited by 1
Knop, F. K., Lund, A., Madsbad, S., Holst, J. J., Krarup, T., & Vilsbøll, T. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-326 · Cited by 1
Koh, G. (2014) · The Korean Journal of Obesity · doi:10.7570/kjo.2014.23.1.6 · Cited by 1
Glucagon receptor family in GtoPdb v.2021.3
BATAILLE, D., Chan, S. L. F., Delagrange, P., Drucker, D. J., Göke, B., Hills, R., Mayo, K. E., Miller, L. J., Salvatori, R., & Thorens, B. (2021) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f29/2021.3 · Cited by 1
Four sidenotes about glucagon peptides
Rehfeld, J. F. (2022) · Peptides · doi:10.1016/j.peptides.2022.170924 · Cited by 1
Advancements and challenges in the management of obesity using pharmacotherapy (Review)
Alotaibi, S. S., Eldrehmy, E. H., Albogami, S. M., Alkhedaide, A. Q., & Dahab, O. (2025) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2025.12912 · Cited by 1
Woodard, J. (2010) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign) · Cited by 1
Morphological Aspects of GLP-1 Expression in the Intestine
Eissele, R. (1997) · Frontiers in diabetes · doi:10.1159/000194729 · Cited by 1
Sequences of Natural Gut Peptides, Related Peptides, and Their Precursors
Yanaihara, C. (1989) · Comprehensive physiology · doi:10.1002/cphy.cp060202 · Cited by 1
Molecular Biology of Gut Peptides
Haun, R. S., Minth, C. D., Andrews, P., & Dixon, J. E. (1989) · Comprehensive physiology · doi:10.1002/cphy.cp060201 · Cited by 1
BATAILLE, D. (1991) · médecine/sciences · doi:10.4267/10608/4478 · Cited by 1
Clinical Syndromes of Gut Hormones
Bloom, S. R. (1990) · Elsevier eBooks · doi:10.1016/b978-0-12-689330-4.50042-0 · Cited by 1
Total synthesis of human glicentin
Mochizuki, T., Ohshima, K., Takatuka, N., Sato, K., Kakuyama, H., Iguchi, K., & Yanaihara, N. (1993) · Springer eBooks · doi:10.1007/978-94-011-1474-5_47 · Cited by 1
Glucagonlike peptide I (7–37) is a potent stimulator of insulin secretion
Mojsov, S., Weir, G. C., & Habener, J. F. (1988) · Springer eBooks · doi:10.1007/978-94-010-9595-2_193 · Cited by 1
Glucagon-like peptide-1 (GLP-1) and satiation
Rüttimann, E. B. (2010) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-a-006089995 · Cited by 3
Synthesis of Gastrointestinal Hormones Using Organic Chemical or Recombinant DNA Techniques
Yanaihara, N., & Yanaihara, C. (1988) · Advances in metabolic disorders · doi:10.1016/b978-0-12-027311-9.50009-3 · Cited by 1
The GIuco-Incretin Hormone Glucagon-Like Peptide-1 and Its β-Cell Receptor
Thorens, B. (1994) · Humana Press eBooks · doi:10.1007/978-1-4612-0241-7_15 · Cited by 2
BATAILLE, D. (1989) · Comprehensive physiology · doi:10.1002/cphy.cp060220 · Cited by 5
Gurd, R. S., & Hoosein, N. M. (1986) · Topics in the neurosciences · doi:10.1007/978-1-4613-2315-0_30
Gastrointestinal Hormones and Obesity
Wang, Y., & Kokkotou, E. G. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1607-5_6
Insulin-Like Growth Factor I Regulation and Its Actions in Skeletal Muscle Growth and Repair
Barton, E. R. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381510-1.00080-6
Maria, J., Lin, C., & Thomas, T. (2012) · InTech eBooks · doi:10.5772/20625
GLP‐1 Biology, Signaling Mechanisms, Physiology, and Clinical Studies
Burcelin, R., Cabou, C., Magnan, C., & Gourdy, P. (2011) · Wiley eBooks · doi:10.1002/9780470910016.ch11
糖尿病の治療戦略として期待されるglucagon-like peptide-1 (GLP-1)
立石, カ. (1999) · 臨床化学 · doi:10.14921/jscc1971b.28.4_167
The activation of the glucagon-like peptide-1 (GLP-1) receptor by peptide and non-peptide ligands
Wishart, C. (2013) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Exocytosis in Type 2 Diabetes- Functional and genetic studies of hormone secretion
Andersson, S. A. (2012) · Lund University Publications (Lund University)
Glucagon-like peptide-1 in nonalcoholic steatohepatitis
Armstrong, M. J. (2014) · University of Birmingham Institutional Research Archive (University of Birmingham)
What's new in…..obesity. Neuroendocrinology of obesity and the potential for new treatments
Field, B. C. T. (2012) · Medicine · doi:10.1016/j.mpmed.2012.10.003
Zhang, Y., Wang, W., Wei, Y., Ma, B., Qiao, K., Ma, Z., Li, C., Zhu, J., & Li, M. (2012) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-012-9305-0
Andreani, T., Silva, A. M., & de Souza, A. L. R. (2010) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Glucagon Secreting Cells Responds to Insulin Secretion In vitro Using Immunocytochemistry
Aswar, M. K., Aswar, U. M., & Subhedar, N. K. (2010) · Journal of Young Pharmacists · doi:10.4103/0975-1483.63154
IDENTIFICATION AND CHARA CTERIZATION OF THE GLUCAGON-LIKE PEPTIDE-2 HORMONAL SYSTEM IN RUMINANTS
Taylor-Edwards, C. C. (2009) · UKnowledge (University of Kentucky)
Heinrich, G., & Habener, J. F. (1987) · Humana Press eBooks · doi:10.1007/978-1-4612-4824-8_4
Marquardt, H., & Mest, J. (1999) · Cited by 1
Regulation of intestinal nutrient uptake by glucagon-like peptide-1 in rats
Shephard, D. M. (1998) · ThinkTech (Texas Tech University)
Measurement of Insulin and Other Glucose-Regulating Peptide Hormones
Müller, G. A. (2015) · Springer eBooks · doi:10.1007/978-3-642-27728-3_66-1
Merchant, C. E. (2011) · cIRcle (University of British Columbia) · doi:10.14288/1.0105089
Johnston, K. L. (2003) · Surrey Research Insight Open Access (The University of Surrey)
Immunologie and Biologie Properties of Glucagon-Like Peptide-1 (GLP-1)
Yanaihara, N., Mochizuki, T., Hoshino, M., SUZUKI, M., Nagashima, T., Ishikawa, J., Sato, K., Takatsuka, N., & Yanaihara, C. (1990) · Elsevier eBooks · doi:10.1016/b978-0-12-689330-4.50033-x
Therapeutic potential of GLP-1 for treatment of diabetes
Meenakshi, & Kumar, A. N. (2015) · International journal of applied research
Non‐Insulin Parenteral Therapies
Vilsbøll, T., Christensen, M., Jorsal, T., & Knop, F. K. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch32
The Role of p21-activated Protein Kinase 1 in Metabolic Homeostasis
Chiang, Y. P. (2014) · TSpace (University of Toronto)
The Role of Short Chain Fatty Acids in Obesity
Rahat-Rozenbloom, S. (2016) · TSpace (University of Toronto)
The Role of Transcription Factor 7-Like 2 in Hepatic Glucose Metabolism
Ip, W. (2014) · TSpace (University of Toronto)
Quast, D. R., & Nauck, M. A. (2017) · Der Diabetologe · doi:10.1007/s11428-017-0268-9 · Cited by 1
Signaling pathways of the endogenous glucagon-like peptide-2 (GLP-2) receptor
Walsh, N. (2001) · TSpace (University of Toronto)
Glucagon receptor family (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
BATAILLE, D., Chan, S. L. F., Delagrange, P., Drucker, D. J., Göke, B., Hills, R., Mayo, K. E., Miller, L. J., Salvatori, R., & Thorens, B. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f29/2019.4
He, S., Zhang, J., Wang, T., Wu, P., Liu, J., Li, M., & Ma, B. (2020) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-020-10123-6
Circadian Secretion of Glucagon-like Peptide-1
Martchenko, A. (2020) · TSpace (University of Toronto)
Markovic, M. A. (2020) · TSpace (University of Toronto)
Glucagon‐Like Peptide‐1 Receptor Activators
Wagner, M., Evers, A., Bossart, M., & Konkar, A. A. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc268
Micheletto, F. (2013) · Padua@research (University of Padova)
グルカゴン製剤におけるGlucagon-like Peptide-1免疫活性の存在
千鶴子, 大., 弘田, 明., 佐藤, 光., 橋本, 文., 大島, 一., & 島, 健. (1987) · 糖尿病 · doi:10.11213/tonyobyo1958.30.29
Dillon, L. S. (1987) · Springer eBooks · doi:10.1007/978-1-4899-2007-2_7
libraries, A. C. F. T. G. A. E. D. (1987) · Elsevier eBooks · doi:10.1016/b978-0-12-512511-6.50005-4
Holst, J. J. (2004) · Elsevier eBooks · doi:10.1016/b0-12-386860-2/00225-2
Williams, J. A. (2021) · doi:10.3998/panc.2021.06
Measurement of Insulin and Other Glucose-Regulating Peptide Hormones
Müller, G. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-05392-9_66
Inkretin-Agonisten: In 30 Jahren vom Geheimtipp zum Bestseller
Nauck, M. A. (2023) · Deutsches Ärzteblatt · doi:10.3238/persdia.2023.11.03.01
Non‐insulin Parenteral Therapies
Vilsbøll, T., Christensen, M., Andersen, A., & Knop, F. K. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch36
Conlon, J. M., & Flatt, P. R. (2024) · Peptides · doi:10.1016/j.peptides.2024.171319
Juel, C. T., Lund, A., Hædersdal, S., Andersen, M. M., Hansen, C. P., Storkholm, J. H., van Hall, G., Hartmann, B., ROSENKILDE, M. M., Kibsgaard, C. J., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06534-z
Sequences of Natural Gut Peptides, Related Peptides, and Their Precursors
Yanaihara, C. (1989) · Comprehensive physiology · doi:10.1002/j.2040-4603.1989.tb01336.x · Cited by 1
Molecular Biology of Gut Peptides
Haun, R. S., Minth, C. D., Andrews, P., & Dixon, J. E. (1989) · Comprehensive physiology · doi:10.1002/j.2040-4603.1989.tb01335.x · Cited by 1
GLP-1 Agonists Can Be Heaven or Hell Dependent Upon Dopaminergic Genetic/Epigenetic AntecedentsPreprint
Mahajan, Y., Mahajan, S., Sharafshah, A., Sunder, K. R., Lewandrowski, K., Mohankumar, K., Lorio, M. P., Dowling, Á., Dowling, R., Bergamaschi, J. P. M., et al. (2025) · Preprints.org · doi:10.20944/preprints202510.1849.v1
Liu, Y., Wu, H., Ma, Q., Lu, Z., Zhao, P., Li, X., Li, M., & Wen, J. (2025) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2025.12.002
Buchanan, K. D. (1992) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-2734-9_2
Gastrointestinale Hormonsysteme und ihre Regulation
Göke, B., de Heer, J., & Göke, R. (2006) · Springer eBooks · doi:10.1007/3-540-28782-5_11
Glucagon-like Peptides and Insulin Sensitivity
Holst, J. J., & Knop, F. K. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-116-5_13
Comparative Neuroendocrinology of Gut Peptides
Dockray, G. J. (1989) · Comprehensive physiology · doi:10.1002/j.2040-4603.1989.tb01342.x
(2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33287-6.00006-5
Srikrishnaraj, A. (2021) · TSpace (University of Toronto)
Schmitt, C. C. (2016) · theses.fr (ABES) · doi:10.70675/a1cd5d6azf620z4554z9020zdff30c94abab · Cited by 2
Assessing the role of the transcription factor E2F1 in β-cells identity, function and plasticity
Friano, M. E. (2021) · theses.fr (ABES) · doi:10.70675/93ae4c67z2303z493aza0d5z5ae0eb9ffee4
Peptide hormone-based combinational pharmacotherapies for chronic metabolic diseases
Chui, Z. S. W., Xue, Y., Wu, X., & Xu, A. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100150
Optimizing GLP-1 Receptor Agonist Use: Mechanisms, Clinical Applications, and Safety Profiles
(2026) · Frontiers research topics · doi:10.3389/978-2-8325-8391-3
Histoire des incrétines GLP-1/GIP – De l’hormone au médicament couteau-suisse
Portha, B. (2026) · Biologie Aujourd hui · doi:10.1051/jbio/2026005
Glucagon-like peptide-1 regulates lipid metabolism through actions in the gut and liver
Lewis, G. F., Feng, J. N., & Jin, T. (2026) · Metabolism and Diseases · doi:10.1016/j.metdis.2026.100023
Pharmacological management of obesity: Current landscape and emerging therapies
Atal, S., Agrawal, C., Gupta, R., & Sadasivam, B. (2026) · Indian Journal of Pharmacology · doi:10.4103/ijp.ijp_37_26
Han, Y., Shon, J., & Park, Y. J. (2026) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2026.2728313
Rehfeld, J. F. (2026) · Endocrinology · doi:10.1007/978-3-319-27318-1_19-2
Glutamine and Glucagon-Like Peptide-1 Response
Greenfield, J. R., & Samocha‐Bonet, D. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1932-1_21
Metadata
- Authors
- Bell, G. I., Sanchez-Pescador, R., Laybourn, P. J., & Najarian, R. C.
- ORCID
- Laybourn, Paul J.
- Venue
- Nature
- Published
- 1983-07
- Volume
- 304
- Issue
- 5924
- Pages
- 368-371
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2003141714
- Cited by
- 593
- References
- 36
- Citations by year
- 2026: 16 · 2025: 21 · 2024: 21 · 2023: 17 · 2022: 12 · 2021: 16 · 2020: 13 · 2019: 17 · 2018: 14 · 2017: 10 · 2016: 16 · 2015: 10 · 2014: 12 · 2013: 8 · 2012: 13
- FWCI
- 36.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- exon duplication, glucagon, glucagon-like peptide-1, glucagon-like peptide-2, signal peptide, gene structure
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Glucagon, Cricetinae, Humans, Insulin, Proinsulin, Protein Precursors, Proglucagon
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.